-
Xiaoping Philip Hu, PhD
… of Minnesota. From 2002-2016, he was Professor and Georgia Research Alliance Eminent Scholar in Imaging in the joint … focus areas is the development of MRI biomarkers for the diagnosis and early detection of Parkinson’s disease. Dr. Hu is a fellow …
-
MJFF Awards $710,000 to Advance Understanding of Parkinson's Disease Subtypes
June 6, 2007
… NEWYORK, NY — The Michael J. Fox Foundation for Parkinson’s Research announced $710,000 in total funding to seven … Therapy of Parkinsonism) study population of 800 early-stage Parkinson’s patients and the PRECEPT (Parkinson … Institute will assess predictive factors — including age at diagnosis, gender, family history and race — that may bear …
-
MJFF Contributing Editor Dave Iverson Profiled in Neurology Now
April 2, 2013
… that Dave is “still going strong,” thanks in part to an early diagnosis of the disease, and an exercise regimen that he … Dave hosts regular audio podcasts with the world's top PD researchers, as well as short video reports on timely …
-
"Patients Are at the Heart:" The Michael J. Fox Foundation's Patient Council
April 4, 2012
… unmet medical needs have shaped our decision-making around research priorities. “Patients have always been at the heart … Co-Founder and Executive Vice Chairman Debi Brooks. “In our early years, we called on patients in ad hoc ways to provide … with patients and caregivers, and their insights into the challenges behind clinical trial participation in …
-
Racial Bias and the Parkinson’s Journey: Reflections from the Staff, Advisors and Community of The Michael J. Fox Foundation
August 2, 2021
… actions I can take to counter diversity and bias in medical research and health care, I am aided by holding the … the manifestation and experience of disease, but research into these topics is rare. Unfortunately, this is one more … disease (YOPD)) at 27, but my symptoms started as early as 17. It took a decade to get the right diagnosis …
-
Alan J. Cross, PhD
… and neurodegeneration. Dr. Cross has over 40 years of research experience within academia and the pharmaceutical … and neurodegenerative disorders and translating this into drug discovery and development programs. Dr. Cross has led research teams from the very early phases of target identification through lead …